Search Results - "Kriger‐Sharabi, Ofra"
-
1
Real‐world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study
Published in Alimentary pharmacology & therapeutics (01-07-2023)“…Summary Background Curcumin and QingDai (QD, Indigo) have been shown to be effective for treating active ulcerative colitis (UC). Aim To evaluate the…”
Get full text
Journal Article -
2
Harnessing the Power of Precision Medicine and Novel Biomarkers to Treat Crohn's Disease
Published in Journal of clinical medicine (04-04-2023)“…Crohn's disease (CD) is a chronic inflammatory condition that affects the gastrointestinal tract. It is part of a spectrum of inflammatory Bowel Diseases…”
Get full text
Journal Article -
3
Cost effectiveness of routine duodenal biopsies in iron deficiency anemia
Published in World journal of gastroenterology : WJG (14-09-2016)“…AIM To investigate the cost effectiveness of routine small bowel biopsies(SBBs) in patients with iron deficiency anemia(IDA) independent of their celiac…”
Get full text
Journal Article -
4
-
5
Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial
Published in Clinical gastroenterology and hepatology (01-02-2024)“…We evaluated the efficacy of herbal combination of curcumin-QingDai (CurQD) in active ulcerative colitis (UC). Part I was an open-label trial of CurQD in…”
Get full text
Journal Article -
6
-
7
CURCUMIN-QINGDAI COMBINATION FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED CLINICAL TRIAL
Published in Inflammatory bowel diseases (26-01-2023)Get full text
Journal Article -
8
Manipulation of the intestinal microbiome-a slow journey to primetime
Published in World journal of clinical cases (26-07-2023)“…The modern medical education system has gradually evolved starting from 1910 incorporating the suggestions by Abraham Flexner, his public disclosure of the…”
Get full text
Journal Article -
9
Switching from Intravenous to Subcutaneous Biological Therapy for Inflammatory Bowel Disease Patients Remains a Challenge
Published in Journal of clinical medicine (27-02-2024)“…Biological inflammatory bowel disease (IBD) medications, once limited to intravenous (IV) administration, can now be administered both via IV and…”
Get full text
Journal Article -
10
Clostridium difficile infection and partial membrane cofactor protein (CD46) deficiency
Published in The Israel Medical Association journal (01-09-2012)Get full text
Journal Article